Clinical Trial

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)

Study acronym: ATHENA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the safety and effectiveness of the Heli-FX EndoAnchor system in AAA subjects who without augmented radial fixation and/or sealing due to an endoleak or migration are at high risk for aneurysm-related complications or who are at high risk of migration or endoleak complications post-procedure, and to support product registration of Heli-FX EndoAnchor system with the National Medical Product Administration (NMPA) in China.
Trial Details
NCT Number NCT07754318
Lead Sponsor Medtronic Cardiovascular
Conditions AAA - Abdominal Aortic Aneurysm
Enrollment 142 participants
Start Date 2026-10
Primary Completion 2028-08 (estimated)
Study Completion 2030-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-10